“Guest Editor: Pellegrino Musto HOW FIRST LINE THERAPY IS CHANGING IN TRANSPLANT-ELIGIBLE MULTIPLE MYELOMA PATIENTS”. Mediterranean Journal of Hematology and Infectious Diseases 17, no. 1 (February 27, 2025): e2025026. Accessed May 1, 2026. https://www.mjhid.org/mjhid/article/view/5924.